The Food and Drug Administration (FDA) issued a consumer alert related to Delta-8 tetrahydrocannabinol (Delta-8 THC), following a recent increase in adverse event reports to FDA and poison control centers. Although Delta-8 THC products have proliferated in the market, FDA has not approved or evaluated any products containing the psychoactive cannabinoid and FDA is concerned
Latest Post
More Posts
The Not So Weaved Web: The Fate of CBD Products is in FDA’s Hands
Subscribe: Subscribe via RSS
Blogs
Firm/Org